Диссертация (1140847), страница 16
Текст из файла (страница 16)
NewDehli: B.I. Publications; 2003. p. 58–61.79.Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethralresection of the prostate (TURP)—incidence, management, and prevention. Eur Urol2006;50(5):969-979.12080.RassweilerJ, Teber D, KuntzR, HofmannR.«Complicationsoftransurethral resection of the prostate (TURP)--incidence, management, and prevention»Eur Urol. 2006 Nov;50(5):969-79; discussion 980. Epub 2006 Jan 3081.Roehrborn C, McConnell J. Etiology, pathophysiology, epidemiology andnatural history of benign prostatic hyperplasia. In: Walsh P, Retik A, Vaughan E, WeinA, editors. Campbell’s Urology. 8th ed.
Philadelphia: Saunders; 2002. pp. 1297–1336.82.Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol2005;7 Suppl 9:S3-S14.83.Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benignprostatic hyperplasia (BPH). Med Clin North Am. 2011 Jan;95(1):87-100. doi:10.1016/j.mcna.2010.08.013.84.Rajkumar Mathur, Gaurav Aggarwal, Bhaskar Satsangi, Fareed Khan, SudarshanOdiya «Comprehensive Analysis of Etiology on the Prognosis of UrethralStrictures» Department of Surgery, M.G.M Medical College & M.Y.H group ofHospitals, Indore, Madhya Pradesh, India Vol 37 (3): 362-370, May - June, 2011.85.Souverein PC, Erkens JA, de la Rosette JJ, et al. Drug treatment of benignprostatic hyperplasia and hospital admission for BPHrelated surgery.
Eur Urol2003;43(5):528-534.86.Starkman JS, Santucci RA. Comparison of bipolar resection of the prostatewith standard transurethral prostatectomy: shorter stay, earlier catheter removal andfewer complications. BJU Int 2005;95(1):69-71.87.Tan A, Liao C, Mo Z, et al. Meta-analysis of holmium laser enucleationversus transurethral resection of the prostate for symptomatic prostatic obstruction. Br JSurg. 2007;94(10):1201-1208.88.Tefekli A, Muslumanoglu AY, Baykai M, et al. A hybrid technique usingbipolar energy in transurethral prostate surgery: a prospective, randomized comparison.J Urol 2005;174(4 Pt 1):1339-1343.89.Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA,Naber KG. European and Asian guidelines on management and prevention of catheterassociated urinary tract infections.
Int J Antimicrob Agents 2008;31S:68-78.12190.Thorner DA, Weiss JP. Benign Prostatic Hyperplasia: Symptoms,SymptomScores, and Outcome Measures. Urol Clin North Am 2009;36(4):417-429.91.Verhamme K, Dieleman J, Bleumink G, et al. Incidence and prevalence oflower urinary tract symptoms suggestive of benign prostatic enlargement in primarycare-the Triumph project. EurUrol 2002;42(4):323-328.92.Vesical calculi: refinement of technique and updated data. Int Urol Nephrol2007;39(1):173-177.93.Walsh P.C. Benign Prostatic hyperplasia: Etiological considerations, InKimball F.A. et al. «New approaches to the Study of Benign prostatic Hyperplasia».Progress in Clinical and Biological research. Vol. 145, NY, 1984, pp. 1-25.94.Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC.
Aprospective microbiologic study of bacteriuria in patients with chronic indwellingurethral catheters. J Infect Dis 1982;146:719-723.95.Warren JW. Catheter-associated urinary tract infections. Int JAntimicrob Agents 2001;17:299-303.96.Wasserman N. Hiperplasia benigna de la próstata: revisión yclasificaciónecográfica.
Radiol Clin North Am 2006;44(5):689-710.97.Wei JT, Calhoun E, Jacobsen SJ. Urologic Diseases in America Project:benign prostatic hyperplasia. J Urol98.2005;173:1256–61.Wein AJ, Kavoussi RL, Novick AC, et al. Campbell-Walsh. Urología.9aedición. Tomo 3, capítulo 86. Buenos Aires: Editorial Panamericana;2007. p. 2740.99.Wendt-Nordahl G, Häcker A, Reich O, et al. The Vista system: a newbipolar resection device for endourological procedures: comparison with conventionalresectoscope. Eur Urol 2004;46(5):586-590.100.Yue DK, McLennan S, Marsh M, et al. Effects of experimental diabetes,uremia, and alnutrition on wound healing.
Diabetes 1987;36(3):295-299.122.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
